Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an MDCK cell suspension culture

Details for Australian Patent Application No. 2008207588 (hide)

Owner Novartis Vaccines and Diagnostics GmbH

Inventors Lubben, Holger; Vorlop, Jurgen; Gregersen, Jens-Peter; Frech, Christian

Agent FB Rice

Pub. Number AU-B-2008207588

Parent 2002338667

Filing date 28 August 2008

Wipo publication date 18 September 2008

Acceptance publication date 19 January 2012

International Classifications

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C12N 5/07 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells or tissues

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 7/02 (2006.01) Viruses, e.g. bacteriophages - Recovery or purification

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

18 September 2008 Application Open to Public Inspection

  Published as AU-B-2008207588

18 September 2008 Complete Application Filed

10 November 2011 Alteration of Name

  The name of the applicant has been altered to Novartis Vaccines and Diagnostics GmbH

19 January 2012 Application Accepted

  Published as AU-B-2008207588

17 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008207589-Projectile firing apparatus

2008207587-Method and apparatus for minimizing redundant enhanced uplink allocation Requests and Fault-Isolating Enhanced Uplink Transmission Failures.